Levodopa-induced dyskinesia (LID) is a common complication after dopamine-replacement therapy in Parkinson's disease. The neural mechanisms underlying LID are far from clear, although significant ...

Veronica Brown lived with chronic fatigue, depression, and anxiety for over 10 years before she learned they were early signs ...

Get detailed information on Levodopa, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Everyone's version of Parkinson's is unique. When I was diagnosed with Parkinson’s in August 2019, a doctor told me that ...

Solengepras is a potentially first-in-class, oral, non-dopaminergic investigational therapy in development for Parkinson’s ...

Michael J Fox has admitted that maintaining his dark sense of humour is becoming increasingly difficult as he continues his ...

CSB has also been associated with male gender and earlier onset of PD.1 Although both dopamine agonists (DAs) and, to a lesser extent, levodopa have been associated with impulsive compulsive ...

FDA IND approval for TB006 is a major achievement for TrueBinding and a significant potential advancement for the treatment of Parkinson’s Disease worldwide,” said Alan K. Jacobs, M.D., FAAN, Chief ...

Its portfolio focuses on three clinical-stage product; neuropathic pain (NP), levodopa-induced dyskinesia (LID), social anxiety disorder (SAD) and suicidal ideation (SI). Its product include AV-101 ...

Vitamin B6 (pyridoxine) is a water-soluble compound involved in over 100 enzyme reactions in the body. It is crucial for ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous ...